Skip to content

Clinical trials

Waldenstrom Macroglobulinemia trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Status: Unknown status Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20053
20071
20092
20111
20162
20172
20181
20191
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Auxilio Mutuo Cancer Center1
Centaurus Biopharma Co., Ltd.1
Clatterbridge Centre for Oncology1
Garden State Cancer Center at the Center for Molecular Medicine and Immunology1
Herbert Irving Comprehensive Cancer Center1
Jonsson Comprehensive Cancer Center1
Kosin University Gospel Hospital1
LifeTime Pharmaceuticals1
Lymphoma Study Association1
Medical College of Wisconsin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia22
Lymphoma, Follicular14
Leukemia, Lymphocytic, Chronic, B-Cell13
Lymphoma, B-Cell, Marginal Zone13
Lymphoma, Mantle-Cell12
Lymphoma11
Lymphoma, Large B-Cell, Diffuse9
Lymphoma, Non-Hodgkin9
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Burkitt Lymphoma8

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.